Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of Hepatology|June 8, 2010
Severe acute hepatitis in the DRESS syndrome: Report of two casesSabela Lens, Gonzalo Crespo, Jose A Carrión, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 11, 2006
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantationJose A Carrión, Miquel Navasa, Jaume Bosch, et al.
Annals of Hepatology|February 25, 2017
Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus TreatmentAlicia Senín, Teresa Broquetas, Nuria Cañete, et al.
Journal of Hepatology|February 17, 2009
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective studyJose A Carrión, Eva Martínez-Bauer, Gonzalo Crespo, et al.
Journal of Clinical Medicine|February 26, 2025
Clinical Ascites and Emergency Procedure as Determinants of Surgical Risk in Patients with Advanced Chronic Liver DiseaseLidia Canillas, Amalia Pelegrina, Fawaz Wasef León, et al.
Journal of Gastroenterology and Hepatology|October 11, 2017
Potential drug-drug interactions of OMBITASVIR, PARITAPREVIR/ritonavir ± DASABUVIR ± ribavirin in clinical practiceElena González-Colominas, María-Carlota Londoño, Rosa M Morillas, et al.
Journal of Hepatology|February 17, 2020
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysisPietro Lampertico, Jose A Carrión, Michael Curry, et al.
World Journal of Gastroenterology|May 9, 2015
Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis CSabela Lens, Jose L Calleja, Ana Campillo, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2025
Predicting Hepatic Decompensation in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease-Related Cirrhosis: The ABID-LSM ModelLuis Calzadilla Bertot, Anna Sòria, Alba Jimenez-Masip, et al.
Hepatology Communications|September 8, 2022
High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort studyOctavi Bassegoda, Jesús Rivera-Esteban, Isabel Serra, et al.
Pageof 2